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Purpose: The aim of this study is to investigate the effects of neuropsychophysical optimization 
(NPPO) protocol treatment by radioelectric asymmetric conveyer (REAC) technology in the 
management of sense of stress and confusion (SSC); an analysis of a single cluster of the 
psychological stress measure (PSM) test.
Patients and methods: The PSM, a self-administered questionnaire, was used to measure 
psychological stress and SSC for a group of 888 subjects. Data were collected immediately 
prior to and following the 4-week REAC-NPPO treatment cycle.
Results: This study demonstrates a significant reduction in scores measuring subjective percep-
tions of stress for subjects treated with one cycle of REAC-NPPO. At the end-point of the study, 
the number of treated subjects reporting symptoms of stress-related SSC on the PSM test was 
significantly reduced, whereas there was no difference in sham-treated subjects.
Conclusion: One cycle of REAC-NPPO appears to reduce subjective perceptions of SSC 
measured by the PSM.
Trial registration: This trial has been registered in the Australian New Zealand Clinical Trials 
Registry as ACTRN12607000497404.
Keywords: stress disorders, adaptation disorders, REAC, NPPO
Introduction
The sense of stress and confusion (SSC)1,2 is a very common symptom. SSC can 
afflict anyone at any age3 of life, regardless of the type of work they do.4–6 Often SSC 
is not perceived by the affected subjects who, for this reason, suffering the failure 
or altered perception of their state, can be committed to physical and psychological 
disorders and/or to implement detrimental behaviors, both to himself and to other 
people. Specific psychometric tests, such as the psychological stress measure (PSM), 
in addition to measuring the overall state of stress, allow us to detect the presence of 
defined stress-related cluster as SSC. Other studies have demonstrated the efficacy of 
neuropsychophysical optimization (NPPO) treatment protocol by radioelectric asym-
metric conveyer (REAC)7,8 in reducing the expression of stress-related symptoms. 
Since SSC is not a dimensional measure of stress-related complaints, this study aimed 
to evaluate only the change in the presence of PSM-cluster subjects in SSC as a result 
of the NPPO or sham treatment, and not the intensity of SSC.9–11 The four12 sets of 
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specific questions of the PSM test were considered valid for 
identifying SSC in a subject.
Material and methods
Participants
This was a naturalistic study, so patients with SSC came 
unsolicited to our private medical center, the Rinaldi Fontani 
Institute in Florence, Italy, which is specialized in stress-
related disorders, and were observed in normal clinical 
practice. During the first visit, each patient was administered 
the PSM test. The first list of subjects was randomized by a 
computer using an about 1:4 ratio.
Patients are thus divided into two groups: the real treat-
ment group (RTG), which will be administered the effective 
therapy, and the sham treatment group (STG). Subjects 
enrolled in this second group were requested for their avail-
ability to participate in a blinded study, where they could 
receive no effective treatment (sham). Upon acceptance, the 
administration of effective therapy at the end of any sham 
treatment was ensured. By using results from the PSM test, 
we selected from both groups those subjects expressing the 
SSC cluster: 513 patients in RTG (RTG-SSC) and a second 
group of 145 subjects (STG-SSC) to whom the sham treat-
ment was administered.
Usually, the patients who attended the Rinaldi Fontani 
Institute exhibit different types of symptomatology. The main 
symptoms reported were disorders of sleep, migrant pain, 
particularly at the cervical and lumbar regions, and decrease 
of libido. In all subjects, symptoms had been present for sev-
eral years, and patients had experienced little or no benefit 
from previous treatments, including drugs, physiotherapy, or 
any of several psychotherapeutic approaches. The subjects 
included in the study were asked to avoid taking specific 
psychotropic drugs. The study was performed in accordance 
with the Declaration of Helsinki. This trial has been registered 
in the Australian New Zealand Clinical Trials Registry as 
ACTRN12607000497404.
Demographic characteristics
RTG included 688 subjects comprising 401 (58.3%) females, 
of average age 42.3 ± 11.3 years, and 287 (41.7%) males, of 
average age 41.1 ± 11.4 years. These patients were treated 
with active REAC. STG included 200 subjects comprising 
123 (61.5%) females, of average age 48.8 ± 19.4 years, and 
77 (38.5%) males, of average age 45.8 ± 18.5 years. These 
patients were treated with inactive REAC. The PSM test 
identifies two subgroups of patients who are in SSC cluster: 
RTG-SSC and STG-SSC. RTG-SSC includes 299 (58.3%) 
females, of average age 42.04 ± 11.3 years, and 214 (41.7%) 
males, of average age 41.04 ± 11.5 years; STG-SSC includes 
90 (62.1%) females, of average age 47.6 ± 19.2 years, and 
55 (37.9%) males, of average age 45.2 ± 18.4 years.
Psychological assessment
The PSM was developed specifically to detect stress levels 
in a nonclinical population.9–11 The PSM usually consists of 
a 49-item self-report pencil and paper questionnaire. In this 
study, we used an electronic version to collect and process 
the data, and to analyze the results. Patients were asked to 
answer questions about their psychological stress using a 
four-point scale to describe the intensity of their condition 
(very much = 4, much = 3, little = 2, none = 1). To detect 
the presence of symptoms of SSC, scores were specifically 
obtained from questions referring to feelings of inadequacy 
(question 33), not having clear ideas, feelings of confusion, 
lack of attention and concentration (question 37), perception 
of a great weight on their shoulders (question 41), and feel-
ing like everything requires a big effort (question 42). Such 
stress-symptoms items show satisfactory content, criterion, 
and construct validity for group-level analysis. It is suggested 
Table 1 Compare means
Sense of stress and  
confusion groups
Treated group Sham-treated group
Total pre- Total post- Age Total pre- Total post- Age
0 Mean 118.53 91.57 42.33 119.76 112.84 50.38
n 175 175 175 55 55 55
Standard deviation 6.620 8.176 11.305 6.75 7.76 19.7
1 Mean 123.90 97.52 41.62 124.17 121.83 46.68
n 513 513 513 145 145 145
Standard deviation 6.233 8.102 11.372 6.79 7.34 18.89
Total Mean 122.53 96.01 41.80 122.96 122.11 47.7
n 688 688 688 200 200 200
Standard deviation 6.747 8.520 11.35 7.04 7.45 19.14
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that the longer scales used to measure psychological stress 
can be replaced with it in survey research.12 In this study, 
the following types of PSM test results are evaluated: total 
points and the presence of SSC.
Statistical analysis
Statistical analysis was performed using SPSS software (v 13; 
SPSS Inc, Chicago, IL) for the McNemar and Wilcoxon 
tests and to compare means. The McNemar test analyzed 
the presence of the SSC symptoms (Table 2), the Wilcoxon 
test was used to evaluate the significance of PSM total points 
(Table 3). To evaluate the effectiveness of this treatment the 
number needed to treat test was used, as an indirect index 
of the effectiveness of treatments: the smaller the value, the 
greater the effectiveness of such treatment and vice versa 
(Table 4). We made a comparison of mean values of the total 
points of the PSM test correlated with the patients belonging 
to the SSC cluster, according to their age; this comparison 
was statistically significant in the sham group, this should 
not alter the significance of the conclusions of this study 
(Table 1).
REAC technology and NPPO therapeutic 
protocol
The REAC is an innovative technology7,8 for biostimula-
tion and/or bioenhancement techniques that induces weak 
radioelectric currents to modulate brain activity. The model 
used in this study (Convogliatore di Radianza Modulante, 
ASMED, Italy) is specific for noninvasive brain stimulation 
techniques. REAC treatment has proved its efficacy in ame-
liorating several stress-related disorders,13–18 depression,18–20 
anxiety,18,20 social anxiety,21 agoraphobia,22 bipolar 
disorders,23 some forms of dementias,24 and impaired motor 
control.25–27 Recently, using specific protocols, REAC tech-
nology has demonstrated the chance to induce stem cell pluri-
potency and differentiation.28 NPPO protocol consists of a 
sequence of seven radiofrequency pulses of 500 milliseconds, 
applied by touching the metallic tip of the REAC probe 
onto seven specific auricular points. This protocol consists 
of 18 sessions, usually administered on alternate days. The 
REAC procedure is painless, and no adverse effects from its 
use have been reported.
Results
Prior to REAC-NPPO, 513 (74.56%) patients in Group A 
were positive for SSC. In STG, SSC was detected in 145 
(72.5%) patients. We have noticed that belonging to the 
cluster SSC is related to the age of the patients (Table 1). 
Following REAC-NPPO, only 231 of 513 patients (45%) 
in RTG still presented symptoms of sense of stress and 
confusion (McNemar chi-square test 280.004, asymptotic 
significance 0.000). In STG, SSC was observed in 94 of 
145 subjects (65%) (Table 2). The Wilcoxon test results are 
statistically significant for the RTG group (asymptotic sig-
nificance [two-tailed] = 0.000, Z = −22.735; P , 0.005) and 
not significant for the STG group (asymptotic significance 
[two-tailed] = 0.361, Z = −0.914) (Table 3). For the analyzed 
champion the number needed to treat test confidence interval 
is between 2.5 and 7.8 (1/0.40–1/0.13), number needed to 
treat test value is equal to 3.83 as demonstrations of effec-
tiveness of the treatment (Table 4).
Discussion
The current study was designed based upon the results of a 
previous pilot study that demonstrated the beneficial effects 
of REAC-NPPO in stress-related disorders,16 and was tar-
geted to assess specific stress-related clusters12 on the PSM 
test.9–11 Although there is a common knowledge that stress 
can be the basis for many diseases and disorders, which can 
also seriously affect the physical and mental health,29 the 
subjective perception of the state of SSC is often denied or 
underestimated by the patients. In fact, asking all patients who 
showed the presence of the cluster SSC in the elaboration of 
the PSM, why they came to our clinic, no one has said that 
the reason for the consultation was for SSC, but for specific 
disorders such as migrant pain, particularly at the cervical 
and lumbar regions, sleep disorders, and decrease of libido. 
Furthermore, asking specifically whether they thought they 
suffered from SSC, only a small percentage, about 10%, 
answered affirmatively, giving it a marginal significance. 
The lack of perception or underestimation of SSC by the 
patient can be considered as a risk factor for health status. 
Table  2  McNemar  test:  psychological  stress  measure  cluster 
SSC population in treated group and sham-treated group before 
and after therapy
Groups Test Results
SSC pre- SSC post-
Treated group  
(t0–t1)
0 1 Asymptotic  
significance 0.000
0 175 0 Chi-square
1 282 231 280.004
Sham-treated  
group (t0–t1)
0 1 Asymptotic  
significance 0.610
0 10 45 Chi-square
1 51 94 0.260
Abbreviation: SSC, sense of stress and confusion.
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Likewise, the failure to recognize or underestimation of SSC 
by the physician, can lead to incorrect treatment, which may 
be of limited effectiveness and/or detrimental. This poses a 
major, larger question, as to whether truly effective drugs 
may be available for preventing or treating SSC (an area of 
enquiry already reviewed).30 Basically, we can confirm that 
there are no drug therapies currently available for preventing 
or treating SSC, but only to blunt certain symptoms, often 
with poor therapeutic response and even side effects. The 
lack of success of drug treatment is not due to ineffective-
ness of the drug, but rather to the wrong prescription for 
nonrecognition or underestimation of the state of SSC by 
the physician. From these considerations, a question arises: 
how can a physician help a patient who comes to him for 
stress-related symptoms, while the patient is not aware of 
this reality? Probably, it would be helpful that the physician 
will be able to make a diagnosis of SSC, not only based on 
the anamnesis, but also using psychometric tests, such as 
PSM, so that the patient will acquire a greater awareness of 
his condition. It may also be useful for the physician, with 
the exception of the acute phases, to avoid an immediate 
drug prescription, while controlling the symptoms over 
time. Finally, it might be worthy that the doctor can provide 
medical treatment, possibly painless, noninvasive, and above 
all, that does not require the conviction of the patient in the 
therapeutic success. REAC-NPPO, on the basis of previous 
evidence, seems to fulfill the requirements to treat, and 
probably, prevent the SSC.
Conclusion
It is documented that electrical currents produced in various 
ways can lead to a change of the electrical activity of the 
nervous system and entire body. In fact, electrical currents 
are tightly entangled with ionic fluxes, and since the REAC 
equipment induces a circulating current due to an oscil-
lating radiofrequency field, it will also elicit a variation in 
the ionic fluxes of the whole body. The REAC technology, 
with its weak radioelectric currents, most likely induces a 
new favorable tuning of bioelectric activity in the central 
nervous system, leading to normalization of “stressed” brain 
function(s). Hence, the REAC-NPPO treatment protocol, 
based on the current findings and the results from other 
double-blinded studies, emerges as a valid therapeutic 
approach to treat stress-related disorders.
Disclosure
Salvatore Rinaldi and Vania Fontani are the inventors of 
radioelectric asymmetric conveyer technology.
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